• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Nippon Life to buy Resolution Life for $8.2 billion, Nikkei says

by December 10, 2024
written by December 10, 2024

TOKYO (Reuters) -Nippon Life Insurance (NS:LIFI) will buy U.S. life insurer Resolution Life Group Holdings for about $8.2 billion in what would be the biggest acquisition ever by a Japanese insurer, business newspaper the Nikkei reported on Tuesday.

Nippon Life will purchase the shares it does not already own in Resolution Life from Blackstone (NYSE:BX) and others to make it a wholly owned subsidiary in the second half of 2025. It will pay for the acquisition with cash on hand.

The deal is the latest example of heavyweight Japanese insurance companies going abroad in search of acquisitions in faster-growing markets, given the limited chance for expansion at home where the population is shrinking and ageing.

A spokesperson for Nippon Life said the company was in talks with Resolution Life, but added it could not disclose what the discussions were about.

Resolution Life and Blackstone declined to comment on the report.

The acquisition marks Nippon Life’s second major investment this year, following its $3.8 billion purchase of a 20% stake in U.S. insurance firm Corebridge Financial in May.

The U.S. market has been a particular buyout focus for Japanese insurance firms.

Property and casualty insurer Tokio Marine Holdings bought speciality insurer HCC Insurance Holdings for $7.5 billion in 2015. It also paid $2.7 billion in 2011 for Delphi Financial and bought Philadelphia Consolidated for $4.7 billion in 2008.

Nippon Life has spent $1.65 billion to acquire 23% of Resolution Life up to now. The Bermuda-based company is a closed-book insurer that purchases existing insurance policies from insurers in the U.S. and other countries, the Nikkei said.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Europe’s STOXX 600 falls as China stimulus boost wanes; focus on US CPI
next post
Centrica extends share buyback plan by £300 mln, total now £1.5 bln

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!








    By signing up, you're cool with getting emails from us. Don’t worry — your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    Recent Posts

    • Elon Musk’s SpaceX acquires xAI

      February 25, 2026
    • The architect of Amazon’s supply chain on running a startup with your spouse

      February 25, 2026
    • Trump administration alleges Nike discriminated against white workers

      February 25, 2026
    • Landmark trial accusing social media companies of addicting children to their platforms begins

      February 25, 2026

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (688)
    • Stock (6,426)

    Latest News

    • Elon Musk’s SpaceX acquires xAI
    • The architect of Amazon’s supply chain on running a startup with your spouse

    Popular News

    • No reason not to cut rates in Dec as of now, ECB’s Holzmann tells paper
    • Pfizer to pay $59.7 million over kickbacks for migraine drug

    About The Significant deals

    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy